• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Infectious Disease

Nationwide treatment regimen more than halves tuberculosis prevalence in China

byMelissa McCoyandAndrew Bishara
March 21, 2014
in Infectious Disease, Public Health
Reading Time: 3 mins read
Nationwide treatment regimen more than halves tuberculosis prevalence in China
Share on FacebookShare on TwitterShare on LinkedIn

Image: PD

1. Over a 20-year period, China reduced prevalence of smear-positive tuberculosis by more than half by shifting tuberculosis treatment from hospitals to public health centers that implemented the directly observed treatment, short-course (DOTS) strategy.

2. The directly observed treatment, short-course (DOTS) regimen was particularly effective at reducing prevalence of known cases of tuberculosis, implying that overall prevalence decrease was primarily due to better treatment rather than by earlier diagnosis of tuberculosis.

Evidence Rating Level: 2 (Good)

Study Rundown: In the 1990s, China extended tuberculosis control to half the population by providing directly observed treatment, short-course (DOTS). By 2000, DOTS was available to the entire population. This study assessed the impact of the DOTS scale-up over a 20-year period. Results of three national tuberculosis prevalence surveys from 1990, 2000, and 2010 were analyzed. In the 1990s, smear-positive disease prevalence decreased only in provinces that had implemented DOTS. After 2000, prevalence was decreased in all provinces, paralleling the extended implementation of DOTS. Overall, smear-positive prevalence fell by 65%. This study’s findings are strengthened by the large sample size and geographical area, which ensured a more accurate national representation of the population. A limitation of this study was that in 1990 and 2000, chest fluoroscopy was used for screening and in 2010 chest radiography was used. Due to the increased sensitivity of radiography reduction of pulmonary cases may have been masked.

Click to read the study in The Lancet

RELATED REPORTS

2MM: AI Roundup- PTSD Prediction, Gait as a Biomarker, Faster Cardiac MRI, and Perinatal Mental Health Chatbots [November 12th, 2026]

Large genetic association study identifies additional Alzheimer disease risk loci and candidate pathways

Relevant Reading: Progress in tuberculosis control and the evolving public-health system in China

In-Depth [prospective study]: This study analyzed longitudinal data from the 1990, 2000, and 2010 national tuberculosis prevalence surveys in China. Individuals 15 years and older from 31 provinces were screened with chest imaging, and those with abnormal imaging findings and/or persistent cough were classified as having suspected tuberculosis. Results were confirmed with chest radiography, sputum-smear, and culture. From 1990 to 2010 smear-positive tuberculosis prevalence fell from 170 cases (95% CI 166-174) to 59 cases (49-72) per 100,000 population. 68 (87%) of these cases were known cases (diagnosed before the survey) comprised the majority of the reduction in overall prevalence. From 1990 to 2000 programmatic changes were minimal. Reporting of cases to the CDC system increased from 460 (19%) of 2453 to 93 (23%) of 374 (p=0.0055), and the proportion of patients who received tuberculosis treatment increased from 2313 (94%) of 2453 to 370 (99%) of 374 (p=0.00014.)

More from this author: Estimated three quarters of people with influenza are asymptomatic [Flu Watch study], Rotavirus vaccine 116E shown effective and affordable in India, Nursing staff cuts associated with increased risk of preventable deaths, Estimated 1 in 14 women worldwide survivors of sexual violence in lifetime

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. 

Tags: chinaDOTSinfectious diseaseprevalencestudytreatmenttuberculosis
Previous Post

Stool DNA testing may improve screening sensitivity of colorectal cancer

Next Post

Cesarean in the second stage associated with endometritis

RelatedReports

Collage of medical tech icons circling a central chip with 'AI Roundup' title and 2 Minute Medicine logo in teal background.
AI Roundup

2MM: AI Roundup- PTSD Prediction, Gait as a Biomarker, Faster Cardiac MRI, and Perinatal Mental Health Chatbots [November 12th, 2026]

November 16, 2026
A senior woman looks thoughtfully, accompanied by a DNA helix, a brain illustration, and cellular motifs, representing Alzheimer's genetic research.
Chronic Disease

Large genetic association study identifies additional Alzheimer disease risk loci and candidate pathways

November 15, 2026
Collage on head injury in adults: a calm man beside an engraved brain drawing, a bicycle helmet and a small penlight
Chronic Disease

Spousal traumatic brain injury is associated with increased mortality in the uninjured partner

November 13, 2026
Collage on urinary incontinence: an older woman smiling calmly beside an engraved bladder, a stopwatch and a teal ribbon
Chronic Disease

Use of β3 adrenergic agonists and anticholinergics for overactive bladder are associated with similar dementia risk

November 13, 2026
Next Post

Cesarean in the second stage associated with endometritis

Initial primary invasive or in situ melanoma increases risk of subsequent invasive melanoma

Child activity levels correlate with mothers’ activity levels

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • 2MM: AI Roundup- PTSD Prediction, Gait as a Biomarker, Faster Cardiac MRI, and Perinatal Mental Health Chatbots [November 12th, 2026]
  • Large genetic association study identifies additional Alzheimer disease risk loci and candidate pathways
  • Pelacarsen lowers lipoprotein(a) but does not reduce major cardiovascular events in patients with established cardiovascular disease
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ new physician-written study summaries monthly, 12,000+ searchable
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.